FDX1 and Parkinson disease: In terms of early diagnosis, the identified DEC-MDRGs (such as DLAT, FDX1, and PDHA1), which are abnormally expressed in PBMCs of PD patients, can serve as non-invasive diagnostic biomarkers, particularly suitable for screening high-risk populations.